EFFECTS OF DIABETIC NEPHROPATHY ON PHOSPHOROUS HOMEOSTASIS
Keywords:
Diabetes Mellitus, Serum Phosphorus, Diabetic Nephropathy, MicroalbuminuriaAbstract
A paradoxical metabolic imbalance in inorganic phosphate occurs from the early onset of diabetes and may lead to a reduction of high energy phosphates and tissue hypoxia. These changes take place in the cells and tissues in which the entry of glucose is not controlled by insulin, and particularly in poorly regulated diabetes patients in whom long term vascular complications are more likely to occur. Diabetic nephropathy is one of the most serious complications of diabetes and can lead to glomerulosclerosis and end stage renal diseases. Ultimately resulting in mortality in diabetic patients. This study is an attempt to find out the serum phosphorus levels in diabetic nephropathy patients and to find its association with HbA1c.
References
I. Revathi R, Amaldas J.(2014) A Clinical study of serum phosphate and magnesium in type II diabetes mellitus. Int J Med Res Health Sci, 3(4): 808-12.
II. S.R Salaqh Hamed, P Pavkovic.(2000) Microalbuminuria and diabetes mellitus. Diabetologia Croatia.31(4):209-21.
III. Arpaci D, Tocoglu AG, Ergenc H, Korkmaz S, Vcar A, Tamer A. (2015) Association of Serum Magnesium level with DM & Diabetic complications. Hippokratia. 19(2): 153-7.
IV. Raul KM , Tungikar S, Soni N, Deshpande S, Raundal S. (2015) Study of serum phosphorus levels and its correlation with clinical profile in patients with diabetic ketoacidosis. IOSR- JDMS. 14(5):1-10.
V. Laroche M, Boyer JF. (2005) Phosphate diabetes, tubular phosphate reabsorption & phosphotonins. Joint, bone, spine revere du rhumatisme.72(5):376-81.
VI. Ditzel J, Lervang HH. (2009) Disturbance of inorganic phosphate metabolism in diabetes mellitus: temporary therapeutic intervention trials. Diabetes Metab Syndr Obes. 2: 173–7.
VII. Willer A, Harreiter J, Pacini G. (2016) Sex and Gender differences in risk, pathophysiology and complications of Type 2 Diabetes Mellitus. Endocr Rev. 37(3): 278-316.
VIII. Rao DV, Pradhan B, Mallikarjuna Y, Reddy R. (2012) Clinical profile of diabetic ketoacidosis in adults. Nepal Journal. 10(2): 80-6.
IX. Bora G, Rajakakati R, Kakati S, Yadav S. (2016) serum inorganic phosphate concentration and glycated hemoglobin percent in type 2 diabetes mellitus. IJHSR. 6(10):96-104.
X. Gertner JM, Tamborlane WV, Horst RL.(1980) Mineral metabolism in diabetes mellitus: changes accompanying treatment with a portable subcutaneous insulin infusion system. Journal of clinical endocrinology and metabolism.5(5): 862-6.
XI. Ugwuja E, Eze N.(2006). Comparative study of serum electrolytes, total protein, calcium and phosphate among diabetic and HIV/AIDS patients in Abakaliki, South eastern Nigeria. The Internet Journal of Laboratory Medicine. 3(2): 1.
XII. Hebden RA, Gardner SM,Benett T,Mac Donald IA.(986). The influence of stertozocin- induced diabetes mellitus on fluid and electrolytes in handling in rats. Clin.Sci. 70(1):111-7.
XIII. Haap M, Hellar E, Thamer E, Tschritter O, Stefan N, Fritsche A.(2006). Association of serum phosphate levels with glucose tolerance, insulin sensitivity and insulin secretion in non-diabetic subjects. European journal of clinical nutrition .60:734-9.
XIV. Najeeb Q, Aziz R, Hamid S.(2014). To evaluate the levels of glycated hemoglobin, serum calcium, magnesium, phosphate, uric acid and microalbuminuria in patients with newly diagnosed type 2 diabetes mellitus. Int.J Res Med Sci. 2(4):1462-5.
XV. Sultan, E.; Taha, I.; Saber, LM. (2008) Altered Bone Metabolic Markers In Type 2 Diabetes Mellitus: Impact of Glycemic Control. Journal of Taibah University Medical Sciences. 2: 104-16.
XVI. Nagasaka S, Murakami T, Uchikawa T, Ishikawa SE, Saito T. (1995) Effect of glycemic control on calcium and phosphorus handling and parathyroid hormone level in patients with non-insulin-dependent diabetes mellitus. Endocrine Journal. 42(3):377-83.
XVII. Zhong N, Xue Xue D, Bao Y, Xue B.(2016) Level of phosphorus and adult type 2 diabetes mellitus. J Cent South Uni (Med sci.). 41(5):502-6.
XVIII. Kalaitzidis R, Tsimihodimos V, Bairaktari E, Siamospoulos KC, Elisaf M. (2005) Disturbances of phosphate metabolism: another feature of Metabolic Syndrome. American journal of kidney diseases. 45(5):851-8.
XIX. Raskin P, Pak CYC. (1981) The effect of chronic insulin therapy on phosphate metabolism in Diabetes Mellitus. Diabetologia. 21(1): 50-3.
XX. Barrett PQ, Aronson PS. (1982) Glucose and alanine inhibition of phosphate transport in renal microvillus membrane vesicles. Am J Physiol. 242(2): F126-F131.
XXI. The diabetes control and complications trail research group. The effect of intensive treatment of diabetes in insulin dependent diabetes mellitus. N Engl J Med. 1993; 329(14): 977-86.
XXII. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. (UKPDS 33). Lancet 998; 352(9131):837-53.
XXIII. Haglin L, Lindblad A, Bygren LO.(2001) Hypophosphataemia in the metabolic syndrome. Gender differences in body weight and blood glucose. Eur J Clin Nutr. 55(6): 493-8.
XXIV. Park W, Kim BS, Lee JE, Huh JK, Kim BJ, Sung KC, et al.(2009) Serum phosphate levels and the risk of cardiovascular disease and metabolic syndrome; a double edged sword. Diabetes Res Clin Pract.83(1): 119-25.
XXV. Arun kumar D, Revathi K, Rajeshwari S, Swaminathan S. (2015). The diagnostic significance of calcium, phosphorus, magnesium and uric acid in type 2 diabetes mellitus and their association to HBA1C. J Chem Pharm Res. 7(8):390-7.
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 International Education and Research Journal (IERJ)
This work is licensed under a Creative Commons Attribution 4.0 International License.
